Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASCA101 for Cachexia in Solid Tumor Patients
NCT07168226Phase 2Recruiting
- Sponsor
- MetaFines
- Start
- May 2026
- Primary completion
- Apr 2028
- Modality
- Large molecule
- Countries
- 1
01
Overview
A Phase 2 trial of ASCA101 in cachexia, sponsored by MetaFines. Started May 2026; status: recruiting.
02
Drugs
ASCA101
03
Conditions
cachexia
Beyond the preview
Go deeper on NCT07168226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07168226.